This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
VEPESID
BRISTOL-MYERS SQUIBB CANADA
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of VEPESID in Canada?
A shortage of VEPESID 50MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 25, 2026), but it has not started yet.
Why is VEPESID not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will VEPESID be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
00616192
Strength
50MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
ETOPOSIDE
Tier
Unrated
Last Updated
2018-12-20
Reason for Shortage
Delay in shipping of the drug.
Past Reports for This Drug
VEPESID has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BRISTOL-MYERS SQUIBB CANADA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02281066
0.5MG · DIN 02282224
120000000CELLS · DIN 02527138
15MG · DIN 02532573
5MG · DIN 02532557
2.5MG · DIN 02532549
10MG · DIN 02532565
100MG · DIN 00360414
125MG · DIN 02163675
250MG · DIN 02163683
250MG · DIN 02163659
500MG · DIN 02163667